Mumbai, Maharashtra, India, June 2026 — Roche Diagnostics has announced a key leadership transition for its India and Neighboring Markets business. Effective August 1, 2026, Marco Valencia Sanchez will assume the role of General Manager, Roche Diagnostics India, succeeding Rishubh Gupta, who has been appointed Head of Subregion Africa for Roche Diagnostics, based in Nairobi, Kenya.
Rishubh Gupta, who joined Roche India in 2023, successfully navigated complex market dynamics and strengthened the organisation’s focus on expanding diagnostic access across India and its neighboring markets. In his new regional role, he will join the Roche Diagnostics EMEA-LATAM Leadership Team.
Reflecting on his tenure, Rishubh Gupta said:
“Leading the India and Neighboring Markets team has been an extraordinary privilege. I am deeply proud of the passion, grit, and customer-first mindset our team has demonstrated in making advanced diagnostics more accessible across the region. As I transition to my new role in Africa, I carry immense gratitude for our partners, clinicians, and team members who have been vital to this journey. I am confident that under Marco’s stellar leadership, Roche India will reach even greater heights.”
Marco Valencia Sanchez assumes leadership of Roche Diagnostics India following a distinguished 17-year career with Roche, during which he has held key global, regional, and affiliate leadership positions. Most recently, he served as Country Manager for Roche Diagnostics Philippines, where he spent the past four years driving significant market growth and operational excellence. He will relocate to Mumbai with his family to assume his new responsibilities.
Commenting on his appointment, Marco Valencia Sanchez said:
“I am honored to step into this role at such a transformative time for the Indian healthcare landscape. The market is experiencing a profound shift, where advanced diagnostic capabilities are becoming central to early intervention and patient outcomes. Building on the strong foundation laid by Rishubh and the team, I am excited by our next chapter. I look forward to deepening our ecosystem partnerships and accelerating the delivery of cutting-edge diagnostics to meet the evolving needs of clinicians and patients across the market.”
The leadership transition reflects Roche Diagnostics’ continued commitment to strengthening its presence in India, expanding access to advanced diagnostics, and supporting improved patient outcomes through innovation and collaboration with healthcare stakeholders across the region.
About Roche Diagnostics India
Roche is the world’s largest biotechnology company. Roche Diagnostics India Pvt. Ltd., established in 2002, operates offices in Mumbai, Chennai, Delhi, and Kolkata, employing more than 400 professionals. The company offers a broad portfolio of innovative diagnostic tests and systems that support early detection, targeted screening, disease evaluation, and patient monitoring. Guided by its purpose of “Doing now what patients need next,” Roche Diagnostics India continues to advance integrated healthcare solutions to address the country’s evolving healthcare needs.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
